Alpro Pharmacy and MSD Malaysia collaborate to enhance cancer care

In a groundbreaking move to improve cancer awareness and accessibility to oncology treatment, Alpro Pharmacy, Malaysia’s largest prescription pharmacy chain, and Merck, Sharp & Dohme (MSD Malaysia), a subsidiary of global healthcare leader Merck & Co., Inc., have entered into a Memorandum of Understanding (MoU). The partnership aims to expand access to oncology medications, raise cancer awareness, and strengthen the availability of oncology treatments, culminating in the establishment of Alpro ONCOHelp, a dedicated one-stop center for cancer patients and their families.

Ph. Joelle Wong, Chief Pharmaceutical Officer of Alpro ONCOHelp, expressed the significance of this collaboration, saying, “Our collaboration with MSD Malaysia marks an achievement in our journey to enhance healthcare access and the quality of life for cancer patients through ONCOHelp. This program is a one-of-a-kind initiative designed to provide access to innovative oncology treatments and complimentary 365 days medical holistic support to cancer patients.”

A comprehensive approach to patient care

MSD Malaysia will provide invaluable insights into the cancer patient journey, contributing to the development of Alpro Pharmacy’s initiative. The ONCOHelp program, tailored to promote increased access to advanced cancer treatments, will benefit from MSD Malaysia’s expertise. This collaborative effort will broaden the scope of outreach, ensuring a more comprehensive and inclusive approach to patient care.

Dr. Abdullahi Sheriff, MSD Managing Director for Malaysia, Singapore, and Brunei, emphasized the dedication of MSD Malaysia to enhance the lives of patients, stating, “We firmly believe that everyone should have access to the medicines and vaccines they require. We are also confident that working with Alpro Pharmacy will yield innovative solutions that will have a positive impact on the lives of numerous cancer patients in Malaysia.”

Both Alpro Pharmacy and MSD share a strong commitment to increasing awareness among medical professionals and the public regarding cancer and the measures for prevention and treatment. Through this collaborative effort, both organizations are working closely toward a shared goal of making a positive and meaningful contribution to the well-being of the Malaysian cancer community, with the aim of enhancing the overall quality of cancer care.

The central ONCOHelp team, comprising healthcare professionals, including doctors, pharmacists, physiotherapists, nutritionists, and dietitians, will provide invaluable patient navigation services. These services include sourcing affordable cancer medications, assisting in funding for eligible patients, and offering complimentary 365-day medical holistic support for registered patients.

For further information about ONCOHelp, individuals can reach out to the ONCOHelp experts via phone call or WhatsApp at 010-2621923 or via email at [email protected].